After Dolly, PPL to work on pigs

Monday 07 September 1998 23:02 BST

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

After Dolly, PPL to work on pigs

PPL Therapeutics, the group which cloned Dolly the sheep to produce high quality protein, hopes to beat rival pharmaceuticals group Novartis in cloning pigs so their hearts can be used for human transplants by 2005.

Reporting a pounds 1.7m increase in pre-tax losses to pounds 6.7m for the first half of the year Ron James, PPL's managing director, said that the next step would be to transplant pigs' kidneys into humans. He added that owing to an acute shortage of human organs, up to 2m patients could benefit from the use of pigs' hearts and kidneys. PPL shares rose 1.5p to 132p.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Stay up to date with notifications from The Independent

Thank you for registering

After Dolly, PPL to work on pigs

Join our commenting forum

Thank you for registering